메뉴 건너뛰기




Volumn 23, Issue 8, 2006, Pages 1105-1112

Meta-analysis: The dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

EID: 33646873948     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02877.x     Document Type: Review
Times cited : (29)

References (48)
  • 1
    • 0029047713 scopus 로고
    • Chronic viral hepatitis and the management of chronic renal failure
    • Martin P Friedman LS. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995 47 : 1231 41.
    • (1995) Kidney Int , vol.47 , pp. 1231-41
    • Martin, P.1    Friedman, L.S.2
  • 2
    • 0037850873 scopus 로고    scopus 로고
    • Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS
    • Burdick RA Bragg-Cresham JL Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2002 63 : 2222 9.
    • (2002) Kidney Int , vol.63 , pp. 2222-9
    • Burdick, R.A.1    Bragg-Cresham, J.L.2    Woods, J.D.3
  • 3
    • 14844335024 scopus 로고    scopus 로고
    • National surveillance of dialysis-associated diseases in the United States, 2002
    • Finelli L Miller JT Tokars JL Alter MJ Arduino M. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005 18 : 52 61.
    • (2005) Semin Dial , vol.18 , pp. 52-61
    • Finelli, L.1    Miller, J.T.2    Tokars, J.L.3    Alter, M.J.4    Arduino, M.5
  • 4
    • 0036021299 scopus 로고    scopus 로고
    • Hepatitis B virus transmission in Brazilian hemodialysis units: Serological and molecular follow-up
    • Teles SA Martins RMB Gomes SA, et al. Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up. J Med Virol 2002 68 : 41 9.
    • (2002) J Med Virol , vol.68 , pp. 41-9
    • Teles, S.A.1    Martins, R.M.B.2    Gomes, S.A.3
  • 5
    • 0345688112 scopus 로고    scopus 로고
    • An outbreak of fulminant hepatitis in immunocompromised hemodialysis patients
    • Igaki N Nakaji M Moriguchi R, et al. An outbreak of fulminant hepatitis in immunocompromised hemodialysis patients. J Gastroenterol 2003 38 : 968 76.
    • (2003) J Gastroenterol , vol.38 , pp. 968-76
    • Igaki, N.1    Nakaji, M.2    Moriguchi, R.3
  • 6
    • 10644273727 scopus 로고    scopus 로고
    • Meta-analysis: The effect of age on immunological response to hepatitis B vaccine in end-stage renal disease
    • Fabrizi F Martin P Dixit V Bunnapradist S Dulai G. Meta-analysis: The effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004 20 : 1053 62.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 1053-62
    • Fabrizi, F.1    Martin, P.2    Dixit, V.3    Bunnapradist, S.4    Dulai, G.5
  • 7
    • 0021204123 scopus 로고
    • Hepatitis B vaccine in patients receiving hemodialysis
    • The Dialysis Vaccine Trial Study Group.
    • Stevens CE Alter HJ Taylor PE Zang EA Harley EJ Szmuness W The Dialysis Vaccine Trial Study Group. Hepatitis B vaccine in patients receiving hemodialysis. N Engl J Med 1984 311 : 496 501.
    • (1984) N Engl J Med , vol.311 , pp. 496-501
    • Stevens, C.E.1    Alter, H.J.2    Taylor, P.E.3    Zang, E.A.4    Harley, E.J.5    Szmuness, W.6
  • 8
    • 0023707839 scopus 로고
    • More about response to hepatitis B vaccine in hemodialysis patients
    • [letter].
    • Vagelli G Calabrese G Mazzotta A Pratesi G Gonella M. More about response to hepatitis B vaccine in hemodialysis patients. Nephron 1988 49 : 171 [letter].
    • (1988) Nephron , vol.49 , pp. 171
    • Vagelli, G.1    Calabrese, G.2    Mazzotta, A.3    Pratesi, G.4    Gonella, M.5
  • 9
    • 0029901127 scopus 로고    scopus 로고
    • Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality
    • Fernandez E Betru MA Gomez R Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996 11 : 1559 63.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 1559-63
    • Fernandez, E.1    Betru, M.A.2    Gomez, R.3    Montoliu, J.4
  • 10
    • 0030070488 scopus 로고    scopus 로고
    • Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection
    • Navarro JF Teruel JL Mateos ML Marcen R Ortuno J. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 1996 16 : 95 7.
    • (1996) Am J Nephrol , vol.16 , pp. 95-7
    • Navarro, J.F.1    Teruel, J.L.2    Mateos, M.L.3    Marcen, R.4    Ortuno, J.5
  • 11
    • 20844432544 scopus 로고    scopus 로고
    • Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis
    • Ahuja TS Kumar S Mansoury H Rodriguez H Kuo YF. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis. Kidney Int 2005 67 : 1136 41.
    • (2005) Kidney Int , vol.67 , pp. 1136-41
    • Ahuja, T.S.1    Kumar, S.2    Mansoury, H.3    Rodriguez, H.4    Kuo, Y.F.5
  • 12
    • 0029873521 scopus 로고    scopus 로고
    • Recombinant hepatitis B vaccine use in chronic hemodialysis patients: Long-term evaluation and cost-effectiveness analysis
    • Fabrizi F Di Filippo S Marcelli D, et al. Recombinant hepatitis B vaccine use in chronic hemodialysis patients: long-term evaluation and cost-effectiveness analysis. Nephron 1996 72 : 536 43.
    • (1996) Nephron , vol.72 , pp. 536-43
    • Fabrizi, F.1    Di Filippo, S.2    Marcelli, D.3
  • 13
    • 0025242036 scopus 로고
    • Genetic basis of nonresponse to hepatitis B vaccine in hemodialysis patients
    • Pol S Legendre C Mattlinger B Berthelot P Krein H. Genetic basis of nonresponse to hepatitis B vaccine in hemodialysis patients. J Hepatol 1990 11 : 385 7.
    • (1990) J Hepatol , vol.11 , pp. 385-7
    • Pol, S.1    Legendre, C.2    Mattlinger, B.3    Berthelot, P.4    Krein, H.5
  • 14
    • 0025818246 scopus 로고
    • Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients
    • Sennesael JJ van der Niepen P Verbeelen DL. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991 40 : 121 8.
    • (1991) Kidney Int , vol.40 , pp. 121-8
    • Sennesael, J.J.1    Van Der Niepen, P.2    Verbeelen, D.L.3
  • 17
    • 0016413833 scopus 로고
    • T lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency
    • Touraine JL Touraine F Revillard JP Brochier J Traeger J. T lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron 1975 14 : 195 298.
    • (1975) Nephron , vol.14 , pp. 195-298
    • Touraine, J.L.1    Touraine, F.2    Revillard, J.P.3    Brochier, J.4    Traeger, J.5
  • 18
    • 0022350045 scopus 로고
    • The retrieval of randomised clinical trials in liver diseases from the medical literature: A comparison of MEDLARS and manual methods
    • Poynard T Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of MEDLARS and manual methods. Control Clin Trials 1985 6 : 271 9.
    • (1985) Control Clin Trials , vol.6 , pp. 271-9
    • Poynard, T.1    Conn, H.O.2
  • 20
    • 0029175205 scopus 로고
    • The response to the hepatitis B virus vaccine in hemodialyzed and peritoneal dialyzed patients: Own experiences
    • Majdan M Polz M Ksiazek A, et al. The response to the hepatitis B virus vaccine in hemodialyzed and peritoneal dialyzed patients: own experiences. Przegl Lek 1995 52 : 307 10.
    • (1995) Przegl Lek , vol.52 , pp. 307-10
    • Majdan, M.1    Polz, M.2    Ksiazek, A.3
  • 21
    • 19444380447 scopus 로고    scopus 로고
    • A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis
    • Liu YL Kao MT Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005 23 : 3957 60.
    • (2005) Vaccine , vol.23 , pp. 3957-60
    • Liu, Y.L.1    Kao, M.T.2    Huang, C.C.3
  • 22
    • 0005814065 scopus 로고
    • Efficacy of hepatitis B vaccination in patients on CAPD compared to patients on hemodialysis
    • Schmid E Augustin R Machleidt C Wisser H Kuhlmann U. Efficacy of hepatitis B vaccination in patients on CAPD compared to patients on hemodialysis. Adv Perit Dial 1987 1 : 1 5.
    • (1987) Adv Perit Dial , vol.1 , pp. 1-5
    • Schmid, E.1    Augustin, R.2    MacHleidt, C.3    Wisser, H.4    Kuhlmann, U.5
  • 23
    • 0023939204 scopus 로고
    • Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin
    • Steketee RW Ziarnick ME Davis JP. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 1988 127 : 772 82.
    • (1988) Am J Epidemiol , vol.127 , pp. 772-82
    • Steketee, R.W.1    Ziarnick, M.E.2    Davis, J.P.3
  • 24
    • 0024348726 scopus 로고
    • Vaccination against hepatitis B in children and adolescent patients on dialysis
    • Drachman R Isacsohn M Rudenski B Drukker A. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 1989 4 : 372 4.
    • (1989) Nephrol Dial Transplant , vol.4 , pp. 372-4
    • Drachman, R.1    Isacsohn, M.2    Rudenski, B.3    Drukker, A.4
  • 25
    • 0029815602 scopus 로고    scopus 로고
    • Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients
    • Khan AN Bernardini J Rault RM Piraino B. Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Perit Dial Int 1996 16 : 370 3.
    • (1996) Perit Dial Int , vol.16 , pp. 370-3
    • Khan, A.N.1    Bernardini, J.2    Rault, R.M.3    Piraino, B.4
  • 26
    • 0029900047 scopus 로고    scopus 로고
    • Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling
    • Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron 1996 73 : 417 20.
    • (1996) Nephron , vol.73 , pp. 417-20
    • Mitwalli, A.1
  • 27
    • 0025258449 scopus 로고
    • Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure
    • Dumann H Meuer S Meyer zum Buschenfelde KH Kohler H. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. Kidney Int 1990 38 : 1164 8.
    • (1990) Kidney Int , vol.38 , pp. 1164-8
    • Dumann, H.1    Meuer, S.2    Meyer Zum Buschenfelde, K.H.3    Kohler, H.4
  • 28
    • 0025981488 scopus 로고
    • The cellular basis for lack of antibody response to hepatitis B vaccine in humans
    • Egea E Iglesias A Salazar M, et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991 173 : 531 8.
    • (1991) J Exp Med , vol.173 , pp. 531-8
    • Egea, E.1    Iglesias, A.2    Salazar, M.3
  • 29
    • 3242816177 scopus 로고    scopus 로고
    • Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients
    • Verkade MA van de Wtering J Klepper M Vaessen LMB Weimar W Betjes GHM. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int 2004 66 : 614 21.
    • (2004) Kidney Int , vol.66 , pp. 614-21
    • Verkade, M.A.1    Van De Wtering, J.2    Klepper, M.3    Vaessen, L.M.B.4    Weimar, W.5    Betjes, G.H.M.6
  • 31
    • 0031008084 scopus 로고    scopus 로고
    • Intradermal versus intramuscular hepatitis B revaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation
    • Fabrizi F Andrulli S Bacchini G Corti M Locatelli F. Intradermal versus intramuscular hepatitis B revaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997 12 : 1204 11.
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 1204-11
    • Fabrizi, F.1    Andrulli, S.2    Bacchini, G.3    Corti, M.4    Locatelli, F.5
  • 32
    • 0345690072 scopus 로고    scopus 로고
    • Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better
    • DaRoza G Loewen A Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003 42 : 1184 92.
    • (2003) Am J Kidney Dis , vol.42 , pp. 1184-92
    • Daroza, G.1    Loewen, A.2    Djurdjev, O.3
  • 33
    • 0022403944 scopus 로고
    • Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non or hyporesponding hemodialysis patients
    • Zaruba K Grob PJ Bolla K. Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non or hyporesponding hemodialysis patients. Surv Immunol Res 1985 4 Suppl. 1 102 6.
    • (1985) Surv Immunol Res , vol.4 , Issue.1 , pp. 102-6
    • Zaruba, K.1    Grob, P.J.2    Bolla, K.3
  • 34
    • 0038315503 scopus 로고    scopus 로고
    • The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease
    • Hassan K Shternberg L Alhaj M, et al. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease. Ren Fail 2003 25 : 471 8.
    • (2003) Ren Fail , vol.25 , pp. 471-8
    • Hassan, K.1    Shternberg, L.2    Alhaj, M.3
  • 36
    • 8244225995 scopus 로고    scopus 로고
    • Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients
    • The Collaborative Groups of Girona.
    • Mauri MJ Valles M The Collaborative Groups of Girona. Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients. Nephrol Dial Transplant 1997 12 : 729 32.
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 729-32
    • Mauri, M.J.1    Valles, M.2
  • 37
    • 0025146947 scopus 로고
    • Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients
    • Quiroga JA Castillo I Porres JC, et al. Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients. Hepatology 1990 12 : 661 3.
    • (1990) Hepatology , vol.12 , pp. 661-3
    • Quiroga, J.A.1    Castillo, I.2    Porres, J.C.3
  • 38
    • 30944443060 scopus 로고    scopus 로고
    • Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients
    • Tong NKC Beran J Kee SA, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005 68 : 2298 303.
    • (2005) Kidney Int , vol.68 , pp. 2298-303
    • Tong, N.K.C.1    Beran, J.2    Kee, S.A.3
  • 39
    • 0035203325 scopus 로고    scopus 로고
    • Hepatitis B vaccine and dialysis: Current issues
    • Fabrizi F Martin P. Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 2001 24 : 683 94.
    • (2001) Int J Artif Organs , vol.24 , pp. 683-94
    • Fabrizi, F.1    Martin, P.2
  • 40
    • 27744587277 scopus 로고    scopus 로고
    • Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease
    • Lacson E Teng M Ong J Vienneau L Ofsthun N Lazarus M. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 2005 9 : 367 75.
    • (2005) Hemodial Int , vol.9 , pp. 367-75
    • Lacson, E.1    Teng, M.2    Ong, J.3    Vienneau, L.4    Ofsthun, N.5    Lazarus, M.6
  • 41
    • 0035957964 scopus 로고    scopus 로고
    • Recommendations for preventing transmission of infections among chronic haemodialysis patients
    • Centers for Disease Control and Prevention.
    • Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic haemodialysis patients. MMWR 2001 50 RR 5 1 43.
    • (2001) MMWR , vol.50 , Issue.5 , pp. 1-43
  • 42
    • 0001542066 scopus 로고
    • Improvement of immune response in dialysis patients to Hevac B vaccine after multiple injections of vaccine
    • Michel P Janin G El Yafi S, et al. Improvement of immune response in dialysis patients to Hevac B vaccine after multiple injections of vaccine. Proc EDTA ERA 1985 22 : 1077 82.
    • (1985) Proc EDTA ERA , vol.22 , pp. 1077-82
    • Michel, P.1    Janin, G.2    El Yafi, S.3
  • 43
    • 0025281484 scopus 로고
    • Heptavax-B in pediatric dialysis patients: Effect of systemic lupus erythematosus
    • (Chesapeake Pediatric Nephrology Study Group).
    • Moxey-Mims MM Preston K Fivush B McCurdy F (Chesapeake Pediatric Nephrology Study Group). Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Pediatr Nephrol 1990 4 : 171 4.
    • (1990) Pediatr Nephrol , vol.4 , pp. 171-4
    • Moxey-Mims, M.M.1    Preston, K.2    Fivush, B.3    McCurdy, F.4
  • 44
    • 0025907790 scopus 로고
    • Poor response to a recombinant hepatitis B vaccine in dialysis patients
    • Fleming SJ Moran DM Cooksley WGE Faoagali JL. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991 22 : 251 7.
    • (1991) J Infect , vol.22 , pp. 251-7
    • Fleming, S.J.1    Moran, D.M.2    Cooksley, W.G.E.3    Faoagali, J.L.4
  • 45
    • 0027952786 scopus 로고
    • Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients
    • El-Reshaid K Al Mufti S Johny KV Sugathan TN. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 1994 12 : 223 8.
    • (1994) Vaccine , vol.12 , pp. 223-8
    • El-Reshaid, K.1    Al Mufti, S.2    Johny, K.V.3    Sugathan, T.N.4
  • 46
    • 0027981332 scopus 로고
    • Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients
    • Fraser GM Ochana N Fenyves D, et al. Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients. J Hepatol 1994 21 : 450 4.
    • (1994) J Hepatol , vol.21 , pp. 450-4
    • Fraser, G.M.1    Ochana, N.2    Fenyves, D.3
  • 47
    • 0036751192 scopus 로고    scopus 로고
    • Vaccination against hepatitis B infection in patients with end stage renal disease
    • Bel'eed K Wright M Eadington D Farr M Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 2002 78 : 538 40.
    • (2002) Postgrad Med J , vol.78 , pp. 538-40
    • Bel'Eed, K.1    Wright, M.2    Eadington, D.3    Farr, M.4    Sellars, L.5
  • 48
    • 0036323587 scopus 로고    scopus 로고
    • Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure
    • Watkins SL Alexander SR Brewer ED, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 2002 40 : 365 72.
    • (2002) Am J Kidney Dis , vol.40 , pp. 365-72
    • Watkins, S.L.1    Alexander, S.R.2    Brewer, E.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.